ለውጦች
On ሰኔ 30, 2022, 09:20:31 (SAST),
-
Added resource Global vaccine deliveries to Africa/global vaccination rollouts
f | 1 | { | f | 1 | { |
2 | "author": "Gemma Ritchie", | 2 | "author": "Gemma Ritchie", | ||
3 | "author_email": "[email protected]", | 3 | "author_email": "[email protected]", | ||
4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | 4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | ||
5 | "extras": [], | 5 | "extras": [], | ||
6 | "groups": [], | 6 | "groups": [], | ||
7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
8 | "isopen": true, | 8 | "isopen": true, | ||
9 | "license_id": "cc-by", | 9 | "license_id": "cc-by", | ||
10 | "license_title": "Creative Commons Attribution", | 10 | "license_title": "Creative Commons Attribution", | ||
11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | 11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | ||
12 | "maintainer": "Gemma Ritchie", | 12 | "maintainer": "Gemma Ritchie", | ||
13 | "maintainer_email": "[email protected]", | 13 | "maintainer_email": "[email protected]", | ||
14 | "metadata_created": "2022-06-30T06:48:12.490391", | 14 | "metadata_created": "2022-06-30T06:48:12.490391", | ||
n | 15 | "metadata_modified": "2022-06-30T07:15:41.041880", | n | 15 | "metadata_modified": "2022-06-30T07:20:31.054752", |
16 | "name": "africa-global-vaccination-rollouts", | 16 | "name": "africa-global-vaccination-rollouts", | ||
17 | "notes": "<p>This folder has three files:\r\n- A table of the types | 17 | "notes": "<p>This folder has three files:\r\n- A table of the types | ||
18 | of Covid-19 vaccines and their manufacturers which are fully approved | 18 | of Covid-19 vaccines and their manufacturers which are fully approved | ||
19 | or approved only for emergency use\r\n- A table of countries that have | 19 | or approved only for emergency use\r\n- A table of countries that have | ||
20 | approved the Covid-19 vaccines\r\n- A table of doses delivered to | 20 | approved the Covid-19 vaccines\r\n- A table of doses delivered to | ||
21 | countries\r\n</p>\r\n*This data was last updated on 30 June 2022.*", | 21 | countries\r\n</p>\r\n*This data was last updated on 30 June 2022.*", | ||
n | 22 | "num_resources": 2, | n | 22 | "num_resources": 3, |
23 | "num_tags": 5, | 23 | "num_tags": 5, | ||
24 | "organization": { | 24 | "organization": { | ||
25 | "approval_status": "approved", | 25 | "approval_status": "approved", | ||
26 | "created": "2022-06-29T10:06:22.005628", | 26 | "created": "2022-06-29T10:06:22.005628", | ||
27 | "description": "Media Hack Collective collect, analyse, and | 27 | "description": "Media Hack Collective collect, analyse, and | ||
28 | visualise data to tell engaging and effective stories. Media Hack | 28 | visualise data to tell engaging and effective stories. Media Hack | ||
29 | Collective are a partner organisation in the Africa Data Hub. Their | 29 | Collective are a partner organisation in the Africa Data Hub. Their | ||
30 | website can be found [here](https://mediahack.co.za/)", | 30 | website can be found [here](https://mediahack.co.za/)", | ||
31 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 31 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
32 | "image_url": "https://mediahack.co.za/_images/logo.png", | 32 | "image_url": "https://mediahack.co.za/_images/logo.png", | ||
33 | "is_organization": true, | 33 | "is_organization": true, | ||
34 | "name": "media-hack-collective", | 34 | "name": "media-hack-collective", | ||
35 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | 35 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | ||
36 | "state": "active", | 36 | "state": "active", | ||
37 | "title": "Media Hack Collective", | 37 | "title": "Media Hack Collective", | ||
38 | "type": "organization" | 38 | "type": "organization" | ||
39 | }, | 39 | }, | ||
40 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 40 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
41 | "private": false, | 41 | "private": false, | ||
42 | "relationships_as_object": [], | 42 | "relationships_as_object": [], | ||
43 | "relationships_as_subject": [], | 43 | "relationships_as_subject": [], | ||
44 | "resources": [ | 44 | "resources": [ | ||
45 | { | 45 | { | ||
46 | "cache_last_updated": null, | 46 | "cache_last_updated": null, | ||
47 | "cache_url": null, | 47 | "cache_url": null, | ||
48 | "created": "2022-06-30T07:07:52.749707", | 48 | "created": "2022-06-30T07:07:52.749707", | ||
49 | "datastore_active": false, | 49 | "datastore_active": false, | ||
50 | "description": "<p>This dataset contains descriptive information | 50 | "description": "<p>This dataset contains descriptive information | ||
51 | about vaccines that are in use in countries around the world or have | 51 | about vaccines that are in use in countries around the world or have | ||
52 | been approved for use (emergency, limited, or full approval), along | 52 | been approved for use (emergency, limited, or full approval), along | ||
53 | with information on who manufacturers the vaccine, type of vaccine, | 53 | with information on who manufacturers the vaccine, type of vaccine, | ||
54 | number of doses required etc. New vaccines will be added when they are | 54 | number of doses required etc. New vaccines will be added when they are | ||
55 | either approved by a country, or a country starts to vaccinate with | 55 | either approved by a country, or a country starts to vaccinate with | ||
56 | them. </p>. \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | 56 | them. </p>. \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | ||
57 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | 57 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | ||
58 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | 58 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | ||
59 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | 59 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | ||
60 | of platform used to carry the vaccine. \r\n\r\n<br | 60 | of platform used to carry the vaccine. \r\n\r\n<br | ||
61 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | 61 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | ||
62 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | 62 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | ||
63 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | 63 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | ||
64 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | 64 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | ||
65 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | 65 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | ||
66 | vaccine, this is sometimes more like a product code than a name eg | 66 | vaccine, this is sometimes more like a product code than a name eg | ||
67 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | 67 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | ||
68 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | 68 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | ||
69 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | 69 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||
70 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | 70 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||
71 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | 71 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | ||
72 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | 72 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | ||
73 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | 73 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | ||
74 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | 74 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | ||
75 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | 75 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | ||
76 | part of the Covax initiative? \r\n\r\n<br | 76 | part of the Covax initiative? \r\n\r\n<br | ||
77 | />**WHO_emergency_use_listing:** Description of where the vaccine is | 77 | />**WHO_emergency_use_listing:** Description of where the vaccine is | ||
78 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | 78 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | ||
79 | />**Data_of_who_recommendation:** Date on which WHO emergency use | 79 | />**Data_of_who_recommendation:** Date on which WHO emergency use | ||
80 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | 80 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | ||
81 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | 81 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | ||
82 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | 82 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | ||
83 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | 83 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | ||
84 | tested against the B.1.315 variant, which is dominant in South Africa? | 84 | tested against the B.1.315 variant, which is dominant in South Africa? | ||
85 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | 85 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | ||
86 | were published. \r\n\r\n<br />**Results_published:** No means results | 86 | were published. \r\n\r\n<br />**Results_published:** No means results | ||
87 | have not been published in peer-reviewed journal. Name of journal if | 87 | have not been published in peer-reviewed journal. Name of journal if | ||
88 | results have been published. \r\n\r\n<br | 88 | results have been published. \r\n\r\n<br | ||
89 | />**date_results-published:**Date when results were published in | 89 | />**date_results-published:**Date when results were published in | ||
90 | peer-reviewed journal\r\n\r\n<br /> | 90 | peer-reviewed journal\r\n\r\n<br /> | ||
91 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | 91 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | ||
92 | "format": "", | 92 | "format": "", | ||
93 | "hash": "", | 93 | "hash": "", | ||
94 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | 94 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | ||
95 | "last_modified": null, | 95 | "last_modified": null, | ||
96 | "mimetype": null, | 96 | "mimetype": null, | ||
97 | "mimetype_inner": null, | 97 | "mimetype_inner": null, | ||
98 | "name": "Vaccine types", | 98 | "name": "Vaccine types", | ||
99 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 99 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
100 | "position": 0, | 100 | "position": 0, | ||
101 | "resource_type": null, | 101 | "resource_type": null, | ||
102 | "revision_id": "2dadd1c7-843b-4deb-ba28-81857a400ef3", | 102 | "revision_id": "2dadd1c7-843b-4deb-ba28-81857a400ef3", | ||
103 | "size": null, | 103 | "size": null, | ||
104 | "state": "active", | 104 | "state": "active", | ||
105 | "url": | 105 | "url": | ||
106 | nLY7XDGB5PAr1oErpwp1PyG_bb9nEFTPql/pubhtml?gid=883047759&single=true", | 106 | nLY7XDGB5PAr1oErpwp1PyG_bb9nEFTPql/pubhtml?gid=883047759&single=true", | ||
107 | "url_type": null | 107 | "url_type": null | ||
108 | }, | 108 | }, | ||
109 | { | 109 | { | ||
110 | "cache_last_updated": null, | 110 | "cache_last_updated": null, | ||
111 | "cache_url": null, | 111 | "cache_url": null, | ||
112 | "created": "2022-06-30T07:15:41.065396", | 112 | "created": "2022-06-30T07:15:41.065396", | ||
113 | "datastore_active": false, | 113 | "datastore_active": false, | ||
114 | "description": "<p> This dataset contains a list of countries | 114 | "description": "<p> This dataset contains a list of countries | ||
115 | and the types of Covid vaccines they are using. It includes when | 115 | and the types of Covid vaccines they are using. It includes when | ||
116 | vaccination started for each vaccine type, where the vaccine is fully | 116 | vaccination started for each vaccine type, where the vaccine is fully | ||
117 | approved for use in that country, the date of approval, where | 117 | approved for use in that country, the date of approval, where | ||
118 | available, and whether it is supplied by Covax. </p>\r\n<p>**Source:** | 118 | available, and whether it is supplied by Covax. </p>\r\n<p>**Source:** | ||
119 | Multiple sources. See Methodology section. Also sources are in the | 119 | Multiple sources. See Methodology section. Also sources are in the | ||
120 | dataset.</p>\r\n<p>**Date of last update:** 20 June 2022 | 120 | dataset.</p>\r\n<p>**Date of last update:** 20 June 2022 | ||
121 | </p>\r\n<p>This data was last updated on 30 June 2022. </p>\r\n<br /> | 121 | </p>\r\n<p>This data was last updated on 30 June 2022. </p>\r\n<br /> | ||
122 | ##Description of variables. \r\n<br />**iso_code:** 3-letter ISO | 122 | ##Description of variables. \r\n<br />**iso_code:** 3-letter ISO | ||
123 | country code. \r\n\r\n<br />**continent:** Name of continent. | 123 | country code. \r\n\r\n<br />**continent:** Name of continent. | ||
124 | \r\n\r\n<br />**country:** Name of country. \r\n\r\n<br />**common | 124 | \r\n\r\n<br />**country:** Name of country. \r\n\r\n<br />**common | ||
125 | _name:** The most commonly used name of a vaccine. eg, BBIBP-CorV is | 125 | _name:** The most commonly used name of a vaccine. eg, BBIBP-CorV is | ||
126 | more commonly known as the Sinopharm vaccine and Ad26.COV2.S is the | 126 | more commonly known as the Sinopharm vaccine and Ad26.COV2.S is the | ||
127 | Johnson & Johnson vaccine. \r\n\r\n<br />**supplier_name:** Name of | 127 | Johnson & Johnson vaccine. \r\n\r\n<br />**supplier_name:** Name of | ||
128 | company that developed the vaccine. Same as develop variable in Sheet | 128 | company that developed the vaccine. Same as develop variable in Sheet | ||
129 | 1: Vaccines. \r\n\r\n<br />**authorised_emergency_use:** Yes or blank | 129 | 1: Vaccines. \r\n\r\n<br />**authorised_emergency_use:** Yes or blank | ||
130 | cell. The table of vaccines used by countries around the world is | 130 | cell. The table of vaccines used by countries around the world is | ||
131 | triggered by a Yes. \r\n\r\n<br />**date_authorised_emergency_use:** | 131 | triggered by a Yes. \r\n\r\n<br />**date_authorised_emergency_use:** | ||
132 | Date when a country\u2019s health ministry authorised a vaccine for | 132 | Date when a country\u2019s health ministry authorised a vaccine for | ||
133 | emergency or limited use. \r\n\r\n<br />**vaccination_started:** Yes | 133 | emergency or limited use. \r\n\r\n<br />**vaccination_started:** Yes | ||
134 | or blank cell. The table of vaccines used by countries around the | 134 | or blank cell. The table of vaccines used by countries around the | ||
135 | world is triggered by a Yes. As is the Africa map vaccine | 135 | world is triggered by a Yes. As is the Africa map vaccine | ||
136 | tracker\r\n\r\n<br />**date_vaccination _started:** Date country | 136 | tracker\r\n\r\n<br />**date_vaccination _started:** Date country | ||
137 | started to vaccinate people with a vaccine. \r\n\r\n<br | 137 | started to vaccinate people with a vaccine. \r\n\r\n<br | ||
138 | />**approved:** Yes or blank cell. Has a vaccine been fully approved | 138 | />**approved:** Yes or blank cell. Has a vaccine been fully approved | ||
139 | by a country? \r\n\r\n<br />**date_approved:** Date country announced | 139 | by a country? \r\n\r\n<br />**date_approved:** Date country announced | ||
140 | full approval for a vaccine. \r\n\r\n<br />**covax_supplied:** Yes or | 140 | full approval for a vaccine. \r\n\r\n<br />**covax_supplied:** Yes or | ||
141 | blank cell. Did country receive vaccine through Covax initiative? | 141 | blank cell. Did country receive vaccine through Covax initiative? | ||
142 | \r\n\r\n<br />**authorised_source:** URLs of all the sources for the | 142 | \r\n\r\n<br />**authorised_source:** URLs of all the sources for the | ||
143 | data in the authorised_emergency_use, date_athorised_emergency_use, | 143 | data in the authorised_emergency_use, date_athorised_emergency_use, | ||
144 | approved and date_approved variables. List of URLs, separated by | 144 | approved and date_approved variables. List of URLs, separated by | ||
145 | semicolons. \r\n\r\n<br />**vaccination_source:** URLs of all the | 145 | semicolons. \r\n\r\n<br />**vaccination_source:** URLs of all the | ||
146 | sources for the data in the vaccination_started and | 146 | sources for the data in the vaccination_started and | ||
147 | date_vaccination_started variables. List of URLs, separated by | 147 | date_vaccination_started variables. List of URLs, separated by | ||
148 | semicolons. | 148 | semicolons. | ||
149 | uWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n", | 149 | uWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n", | ||
150 | "format": "", | 150 | "format": "", | ||
151 | "hash": "", | 151 | "hash": "", | ||
152 | "id": "b905738c-ce6a-40d6-b628-482a48364993", | 152 | "id": "b905738c-ce6a-40d6-b628-482a48364993", | ||
153 | "last_modified": null, | 153 | "last_modified": null, | ||
154 | "mimetype": null, | 154 | "mimetype": null, | ||
155 | "mimetype_inner": null, | 155 | "mimetype_inner": null, | ||
156 | "name": "Africa/global vaccination rollouts", | 156 | "name": "Africa/global vaccination rollouts", | ||
157 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 157 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
158 | "position": 1, | 158 | "position": 1, | ||
159 | "resource_type": null, | 159 | "resource_type": null, | ||
n | 160 | "revision_id": "2dadd1c7-843b-4deb-ba28-81857a400ef3", | n | 160 | "revision_id": "e8338005-0c8f-478d-a679-ceef6b701cb4", |
161 | "size": null, | 161 | "size": null, | ||
162 | "state": "active", | 162 | "state": "active", | ||
163 | "url": "", | 163 | "url": "", | ||
t | t | 164 | "url_type": null | ||
165 | }, | ||||
166 | { | ||||
167 | "cache_last_updated": null, | ||||
168 | "cache_url": null, | ||||
169 | "created": "2022-06-30T07:20:31.078417", | ||||
170 | "datastore_active": false, | ||||
171 | "description": "<p>This dataset lists all countries that have | ||||
172 | received vaccines from the Covax initiative, through bi-lateral | ||||
173 | donations, bought from pharmaceutical companies, from the Africa | ||||
174 | Vaccine Acquisition Trust, the vaccine received, the number of doses | ||||
175 | and the date received. </p>\r\n\r\n<br /> *Last updated on 30 June | ||||
176 | 2022*. \r\n<br />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | ||||
177 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | ||||
178 | country. \r\n\r\n<br />**common _name:** The most commonly used name | ||||
179 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||||
180 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||||
181 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | ||||
182 | vaccine. \r\n \r\n<br />**doses_received:** Number of doses received | ||||
183 | in a particular shipment. \r\n\r\n<br />**bought_donated:** | ||||
184 | \u201cBought\u201d means a country bought the vaccines, | ||||
185 | \u201cDonated\u201d means they were donated, \u201cCovax\u201d means | ||||
186 | they came via Covax, \u201cprivate\u201d when private institutions buy | ||||
187 | vaccines; \u201csold\u201d when a country sells vaccines they received | ||||
188 | to another country; \u201cdonated-out\u201d is when a country donates | ||||
189 | vaccines to another with no expectation of reciprocity. \r\n\r\n<br | ||||
190 | />**donor:** Name of the country or group of countries supplying the | ||||
191 | vaccines received. \r\n\r\n<br />**covax:** Yes or No variable. Is | ||||
192 | the vaccine part of the Covax initiative? \r\n\r\n<br | ||||
193 | />**date_received:** Date shipment of vaccines was delivered. | ||||
194 | \r\n\r\n<br />**source:** URL link to source of information. | ||||
195 | \r\n\r\n<br />**source_2:** URL link to source of information. | ||||
196 | \r\n\r\n<br />**source_3:** URL link to source of | ||||
197 | vn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)", | ||||
198 | "format": "", | ||||
199 | "hash": "", | ||||
200 | "id": "09545054-d15d-45a0-b49a-3ab37a934c78", | ||||
201 | "last_modified": null, | ||||
202 | "mimetype": null, | ||||
203 | "mimetype_inner": null, | ||||
204 | "name": "Global vaccine deliveries", | ||||
205 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||||
206 | "position": 2, | ||||
207 | "resource_type": null, | ||||
208 | "revision_id": "e8338005-0c8f-478d-a679-ceef6b701cb4", | ||||
209 | "size": null, | ||||
210 | "state": "active", | ||||
211 | "url": | ||||
212 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=789081741&single=true&output=csv", | ||||
164 | "url_type": null | 213 | "url_type": null | ||
165 | } | 214 | } | ||
166 | ], | 215 | ], | ||
167 | "revision_id": "79c31d0c-fc4c-4ca7-a519-555f6cfcdc3f", | 216 | "revision_id": "79c31d0c-fc4c-4ca7-a519-555f6cfcdc3f", | ||
168 | "state": "draft", | 217 | "state": "draft", | ||
169 | "tags": [ | 218 | "tags": [ | ||
170 | { | 219 | { | ||
171 | "display_name": "Africa", | 220 | "display_name": "Africa", | ||
172 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | 221 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | ||
173 | "name": "Africa", | 222 | "name": "Africa", | ||
174 | "state": "active", | 223 | "state": "active", | ||
175 | "vocabulary_id": null | 224 | "vocabulary_id": null | ||
176 | }, | 225 | }, | ||
177 | { | 226 | { | ||
178 | "display_name": "Covax", | 227 | "display_name": "Covax", | ||
179 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | 228 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | ||
180 | "name": "Covax", | 229 | "name": "Covax", | ||
181 | "state": "active", | 230 | "state": "active", | ||
182 | "vocabulary_id": null | 231 | "vocabulary_id": null | ||
183 | }, | 232 | }, | ||
184 | { | 233 | { | ||
185 | "display_name": "Covid-19", | 234 | "display_name": "Covid-19", | ||
186 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | 235 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | ||
187 | "name": "Covid-19", | 236 | "name": "Covid-19", | ||
188 | "state": "active", | 237 | "state": "active", | ||
189 | "vocabulary_id": null | 238 | "vocabulary_id": null | ||
190 | }, | 239 | }, | ||
191 | { | 240 | { | ||
192 | "display_name": "Covid-19 vaccines", | 241 | "display_name": "Covid-19 vaccines", | ||
193 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | 242 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | ||
194 | "name": "Covid-19 vaccines", | 243 | "name": "Covid-19 vaccines", | ||
195 | "state": "active", | 244 | "state": "active", | ||
196 | "vocabulary_id": null | 245 | "vocabulary_id": null | ||
197 | }, | 246 | }, | ||
198 | { | 247 | { | ||
199 | "display_name": "vaccines", | 248 | "display_name": "vaccines", | ||
200 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | 249 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | ||
201 | "name": "vaccines", | 250 | "name": "vaccines", | ||
202 | "state": "active", | 251 | "state": "active", | ||
203 | "vocabulary_id": null | 252 | "vocabulary_id": null | ||
204 | } | 253 | } | ||
205 | ], | 254 | ], | ||
206 | "title": "Africa/global vaccination rollouts", | 255 | "title": "Africa/global vaccination rollouts", | ||
207 | "type": "dataset", | 256 | "type": "dataset", | ||
208 | "url": "Multiple sources. See Methodology section", | 257 | "url": "Multiple sources. See Methodology section", | ||
209 | "version": "" | 258 | "version": "" | ||
210 | } | 259 | } |